Common stock, par value $0.0001 per share
- Symbol
- VEEA
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01, 9.01 · 8-K
Veea Inc.
VEEANASDAQEQUITYCurrent
Other Events
Item 8.01. Other Events. On September 14, 2026 Veea Inc. (the “Company”) announced the signing of a non-binding term sheet with NovaGen Group B.V. (“NovaGen”) for a proposed business combination. NovaGen is a personalized regenerative medicine and longevity company headquartered in Amsterdam.…
Company context
We are dedicated to simplifying the journey towards creating a world in which virtually everyone and everything is intelligently connected, while bringing applications and artificial intelligence (“AI”) to the edge of the network. Most service providers, equipment suppliers, system integrators and even hyperscalers have adopted or advocated for similar solutions to various degrees either independently or in collaboration with the Company. However, to our knowledge, we are the first to market with patented technologies that a) bring virtualized data center capabilities to the far edge of the network, commonly referred to as the Device Edge, where all wired and wireless devices connect to the network (the “Edge”), b) spawns hyperconvergence of computing, multiaccess communications and storage, (“Edge Computing”) c) provides for Cloud-managed applications at the Edge (“Hybrid Edge-Cloud Computing”), and d) enables machine learning with AI training, inferencing, and Agentic AI at the Edge (“Edge AI”) including AI-driven cybersecurity for heterogenous networks. Such networks have given rise through any combination of our developed devices and third-party devices, with CPUs, GPUs, TPUs, DPUs and/or NPUs, that run on the VeeaONE platform’s software stack (“VeeaWare”). Our end-to-end edge-cloud platform is referred to as VeeaONETM (“VeeaONE”) platform.
Current securities
Recent company filings
- DEF 14A filingNov 10, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsOct 9, 2026
- Other EventsOct 6, 2026
- Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementOct 2, 2026
- Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD DisclosureAug 26, 2026
Registered securities in this filing
Veea Inc. · 8-K · Filed 2026-09-16
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share
- Symbol
- VEEAW
- Exchange
- NASDAQ
- Classification
- WARRANT
- Status
- Current
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events.
On September 14, 2026 Veea Inc. (the “Company”)
announced the signing of a non-binding term sheet with NovaGen Group B.V. (“NovaGen”) for a proposed business combination.
NovaGen is a personalized regenerative medicine
and longevity company headquartered in Amsterdam.
The proposed combination would launch NovaGen
Health Networks, a connected global health platform integrating Veea’s HealthLynx platform with global cloud service capabilities,
that incorporate edge-cloud computing, connectivity and cybersecurity capabilities with NovaGen’s cellular reprogramming science
and clinical services.
The parties are targeting execution of a definitive
agreement within the coming weeks. The transaction remains subject to the execution of definitive agreements, completion of customary
due diligence, including intellectual property, valuation and other items, receipt of all necessary shareholder and regulatory approvals,
and other customary closing conditions.
There can be no assurance
that the parties will negotiate or execute definitive agreements, that the proposed transaction will be consummated on the terms in the
term sheet, on the contemplated timeline, or at all, or that any definitive agreements, if executed, will not contain terms materially
different from those in the term sheet.
A copy of the joint press release issued by
the parties announcing the signing of the non-binding term sheet is attached hereto as Exhibit 99.1.
Filed exhibits (1)
EX-99.1 2 ea030572101ex99-1.htm PRESS RELEASE DATED SEPTEMBER 14, 2026 Exhibit 99.1 Veea Inc. and NovaGen announce potential merger to launch an Edge AI-Powered Global Health Platform Proposed combination seeks to establish a Nasdaq-listed longevity and precision-health platform, complementing Veea’s continuing edge AI infrastructure business; GeoNova Capital commits US$10 million as cornerstone institutional investor New York / Amsterdam, [DATE] - Veea Inc. (NASDAQ: VEEA), a provider of AI-powered, cybersecure edge infrastructure, and NovaGen Group B.V., a personalized regenerative medicine and longevity company, today announced they have signed a term sheet to combine and are targeting execution of a definitive business combination agreement within the coming weeks. In connection with the business combination, the parties have also announced an agreement to launch NovaGen Health Networks: a connected health platform integrating Veea’s edge computing, connectivity and cybersecurity capabilities with NovaGen’s cellular reprogramming science and clinical services. Initial deployments will begin at NovaGen clinics and partner hospitals in Q4 2026. The platform, built on VeeaO…
Open exhibit ↗